Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 30-Jun 2023. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 13267811000202112 | Product containing only cabotegravir in oral dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 13267821000202116 | Cabotegravir only product in oral dose form | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing only cabotegravir in oral dose form (medicinal product form) | Is a | Product containing only cabotegravir (medicinal product) | true | Inferred relationship | Some | ||
| Product containing only cabotegravir in oral dose form (medicinal product form) | Has manufactured dose form | Oral dose form | true | Inferred relationship | Some | ||
| Product containing only cabotegravir in oral dose form (medicinal product form) | Plays role | Antiretroviral therapeutic role | true | Inferred relationship | Some | ||
| Product containing only cabotegravir in oral dose form (medicinal product form) | Has active ingredient | Cabotegravir (substance) | true | Inferred relationship | Some | 1 | |
| Product containing only cabotegravir in oral dose form (medicinal product form) | Is a | Cabotegravir-containing product in oral dose form | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Cabotegravir (as cabotegravir sodium) 30 mg oral tablet | Is a | True | Product containing only cabotegravir in oral dose form (medicinal product form) | Inferred relationship | Some |
This concept is not in any reference sets
FHIR